For those living with Inflammatory Bowel Disease (IBD)—a group of conditions that includes Crohn’s disease and ulcerative colitis—life is a daily battle. These chronic autoimmune diseases cause inflammation in the digestive tract, leading to symptoms such as abdominal pain, diarrhea, fatigue, weight loss, and nutritional deficiencies. While current treatments have significantly improved outcomes for many, a large number of patients still struggle with treatment-resistant disease, frequent flare-ups, and a diminished quality of life.

Enter Spoke Research, a clinical research organization based in Cape Town, South Africa. Since 2017, Spoke Research has been leading innovative clinical trials focused on digestive health—particularly for Crohn’s and ulcerative colitis patients. With a strong commitment to patient care, ethical research, and scientific excellence, Spoke is helping to transform how IBD is treated.

In this article, we’ll explore the impact of IBD, why research is vital for advancing care, and how Spoke Research is offering new hope to patients across the region through their cutting-edge clinical trial programs.

🔍 What Is IBD, and Why Is It So Challenging to Treat?

IBD includes two main conditions:

• Crohn’s disease, which can affect any part of the gastrointestinal tract (from mouth to anus), often in a patchy manner, and can penetrate deeply into the bowel wall.
• Ulcerative colitis, which is limited to the colon and rectum and affects the innermost lining in a continuous pattern.

Though the exact cause is unknown, IBD is believed to be the result of an overactive immune response, triggered by a combination of genetic predisposition, environmental factors, and changes in the gut microbiome.

Common challenges include:

• Frequent flare-ups that disrupt daily life
• Fatigue and malabsorption, impacting nutrition and energy levels
• Mental health effects, including anxiety and depression
• Side effects from current medications, such as immunosuppressants and steroids
• Surgical interventions, which may be needed when medications fail

Despite the progress in biologic therapies, not all patients respond, and some lose effectiveness over time. That’s why ongoing clinical research is critical—to discover better, safer, and more personalized treatment options.

🌍 The Role of Clinical Trials in Advancing IBD Care

Clinical trials are research studies that evaluate new medical treatments, therapies, or strategies to determine their safety and effectiveness. For IBD, trials often focus on:

• Small molecule therapies that regulate inflammation
• Microbiome therapies or dietary interventions
• Combination therapies or new treatment regimens

Clinical trials are conducted in phases:

• Phase I: Safety and dosage
• Phase II: Efficacy and side effects
• Phase III: Larger population comparison with standard care
• Phase IV: Post-marketing monitoring

Participation in a clinical trial gives patients access to treatments years before public availability, and the findings contribute to global medical knowledge that improves care for millions.

🧬 Meet Spoke Research: Innovators in IBD Trials

Spoke Research, founded by Dr. Gosia George and supported by gastroenterologist Dr. Eduan Deetlefs, has built a strong reputation for delivering high-quality, ethically driven clinical trials in gastroenterology.

Specializing in Crohn’s disease and ulcerative colitis, the team is passionate about offering patients not just access to treatment, but to hope, dignity, and better outcomes.

Why Spoke Research Stands Out:

✅ Patient-First Philosophy

Spoke’s team is deeply invested in the patient journey. They understand that clinical trials can be intimidating, and they make it a priority to ensure every participant feels informed, supported, and cared for.

✅ Gastroenterology Expertise

With dedicated IBD specialists involved in the trials, patients receive advanced medical insight and care from professionals who understand the complexity of these diseases.

✅ Access to Global Innovation

By partnering with international pharmaceutical companies and academic research organizations, Spoke brings world-class treatments to local patients in South Africa at no cost to the patient.

✅ Community Impact

Beyond advancing treatment, Spoke Research helps bridge healthcare access gaps, especially for patients who cannot afford expensive biologics or who have run out of locally available options.

👥 Who Should Consider a Clinical Trial at Spoke?

Clinical trials are open to people who meet specific criteria based on their diagnosis, treatment history, and current health status.

You may be eligible if:

• You’ve been diagnosed with Crohn’s disease or ulcerative colitis
• You’re experiencing active symptoms or flare-ups
• You haven’t responded to current treatment plans
• You’re interested in contributing to research while receiving expert care

Spoke Research accepts both referrals from healthcare providers and direct applications from patients.

🏥 What to Expect: The Clinical Trial Journey at Spoke

Many patients are unsure of what a clinical trial involves. Spoke makes the process transparent and patient friendly.

🔹 Step 1: Pre-Screening & Information

Patients meet with the Spoke team to learn about the trial, its goals, and what participation involves. Medical records are reviewed to determine eligibility.

🔹 Step 2: Informed Consent

Before joining, participants review a detailed consent form that outlines potential benefits and risks. Questions are welcomed, and participation is completely voluntary.

🔹 Step 3: Screening Tests

Initial assessments include bloodwork, colonoscopy, stool tests, and health questionnaires to establish a baseline.

🔹 Step 4: Treatment Phase

Patients receive either the investigational therapy or placebo, depending on the trial. IBD trials use add-on models, meaning patients continue their regular treatment as well.

🔹 Step 5: Regular Check-Ins

Participants attend scheduled follow-ups for lab monitoring, symptom tracking, and wellness checks. Side effects or concerns are addressed quickly by the medical team.

🔹 Step 6: Completion & Continued Support

At the end of the study, follow-up assessments ensure safety and help researchers evaluate long-term effects. Patients may be referred back to their usual care team or invited to future studies.

💬 Patient Stories: Real Impact, Real Lives

“I had exhausted all treatment options. Joining a trial with Spoke was life changing. Not only did my symptoms improve, but I felt seen and supported the whole way.” – Thabo, 37, Cape Town

“I was nervous at first, but the team explained everything. The care was better than anything I’ve had before.” – Cindy, 45, ulcerative colitis patient

These stories highlight how Spoke Research is not just conducting science—they’re transforming patient journeys.

🧠 Addressing Common Questions & Concerns

❓ Are clinical trials safe?

Yes. All trials at Spoke follow strict international safety protocols and are approved by SAHPRA and Ethics Review Boards. Patients are monitored closely throughout.

❓ Will I get a placebo?

Not all trials use placebos. Even when they do, patients still receive standard care. Many IBD studies are open-label or add-on trials, minimizing placebo use.

❓ Can I stop the trial?

Absolutely. Participation is voluntary, and patients can withdraw at any time without affecting their regular healthcare.

🔍 How to Join a Trial at Spoke Research

If you’re living with Crohn’s or ulcerative colitis and want to explore clinical trial opportunities, here’s how to get started:

1. Visit Spoke Research
2. Call or email the team for a consultation
3. Talk to your doctor about a referral
4. Follow Spoke on social media for trial updates and patient education

🧩 The Bigger Picture: Why Research Matters

Each patient who joins a clinical trial contributes to a larger mission: improving the future of IBD care. Through your participation:

• New medications become available to those in need
• Global research moves forward
• You empower future generations to live with less pain and more hope

✅ Conclusion: A Better Future Begins with Research

Crohn’s disease and ulcerative colitis are lifelong conditions—but they don’t have to mean a life of suffering. Through dedication, science, and compassionate care, Spoke Research is helping patients fight back against IBD with access to promising new treatments.

If you’re searching for solutions where standard therapies have failed, consider Spoke Research not just as a clinic—but as a partner in your healing journey.

📞 Ready to Learn More?

Spoke Research – Cape Town, South Africa
💻 www.spokeresearch.co.za
📧 info@spokeresearch.co.za
📞 Call 021 531 6402

Be part of something bigger. Join the fight against IBD—and help shape the future of care.